EUVIMEDEUVIMED entdecken
Crossref

Ameliorative effect of gallic acid on doxorubicin-induced cardiac dysfunction in rats

Temiday O Omóbòwálé, Ademola A Oyagbemi, Ayorinde M Folasire, Temitayo O Ajibade, Ebunoluwa R Asenuga, Olumuyiwa A Adejumobi, Olufunke E Ola-Davies, Orotusin Oyetola, Gana James, Adeolu A Adedapo, Momoh A Yakubu

Journal of Basic and Clinical Physiology and Pharmacology · 26.01.2018 · 29 (1) · 19-27

DOI: 10.1515/jbcpp-2016-0194 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Basic and Clinical Physiology and Pharmacology, online erschienen am 09.10.2017. Verfasst von Temiday O Omóbòwálé und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Medicine, University of Ibadan, Ibadan, Nigeria. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The use of doxorubicin (DOX) as an antineoplastic agent has been greatly limited because of the myriad of toxic sequelae associated with it. The aim of this study was to assess the protective effects of gallic acid (GA) on DOX-induced cardiac toxicity in rats.

Methods

Sixty male rats (Wistar strain) were used in this study. They were divided into six groups (A–F) each containing 10 animals. Group A was the control. Rats in Groups B, C, and D were treated with DOX at the dosage of 15 mg/kg body weight i.p. Prior to this treatment, rats in Groups C and D had been treated orally with GA for 7 days at the dosage of 60 and 120 mg/kg, respectively. Animals from Groups E and F received only 60 and 120 mg/kg GA, respectively, which were administered orally for 7 days.

Results

The exposure of rats to DOX led to a significant (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsAntioxidantsCardiotoxicityCreatine KinaseDoxorubicinElectrocardiographyGallic AcidHeartHeart RateL-Lactate DehydrogenaseMaleMyocardiumProtective AgentsRatsRats, Wistar

Stichwörter der Autor:innen

antioxidantcardiotoxicitydoxorubicinelectrocardiogramgallic acidserum biomarkers

Substanzen

AntioxidantsProtective AgentsGallic AcidDoxorubicinL-Lactate DehydrogenaseCreatine Kinase

Autor:innen und Institutionen

  • Department of Veterinary Medicine, University of Ibadan, Ibadan, Nigeria.
  • Department of Veterinary Physiology and Biochemistry, Faculty of Veterinary Medicine, University of Ibadan, Ibadan, Nigeria.
  • Department of Radiation Oncology, College of Medicine, University of Ibadan, Ibadan, Nigeria.
  • Department of Veterinary Physiology, Pharmacology and Biochemistry, University of Benin, Benin City, Nigeria.
  • Department of Veterinary Pharmacology and Toxicology, University of Ibadan, Ibadan, Nigeria.
  • Department of Environmental and Interdisciplinary Sciences, College of Science, Engineering and Technology, Vascular Biology Unit, Center for Cardiovascular Diseases, COPHS, Texas Southern University, Houston, TX, USA.

Zitieren

APA

Omóbòwálé, T. O., Oyagbemi, A. A., Folasire, A. M., Ajibade, T. O., Asenuga, E. R., Adejumobi, O. A., Ola-Davies, O. E., Oyetola, O., James, G., Adedapo, A. A., & Yakubu, M. A. (2018). Ameliorative effect of gallic acid on doxorubicin-induced cardiac dysfunction in rats. Journal of Basic and Clinical Physiology and Pharmacology, 29(1), 19-27. https://doi.org/10.1515/jbcpp-2016-0194

Vancouver

Omóbòwálé TO, Oyagbemi AA, Folasire AM, Ajibade TO, Asenuga ER, Adejumobi OA, et al. Ameliorative effect of gallic acid on doxorubicin-induced cardiac dysfunction in rats. Journal of Basic and Clinical Physiology and Pharmacology. 2018;29(1):19-27. doi:10.1515/jbcpp-2016-0194

BibTeX
@article{Ombwl2018,
  author = {Omóbòwálé, Temiday O and Oyagbemi, Ademola A and Folasire, Ayorinde M and Ajibade, Temitayo O and Asenuga, Ebunoluwa R and Adejumobi, Olumuyiwa A and Ola-Davies, Olufunke E and Oyetola, Orotusin and James, Gana and Adedapo, Adeolu A and Yakubu, Momoh A},
  title = {Ameliorative effect of gallic acid on doxorubicin-induced cardiac dysfunction in rats},
  journal = {Journal of Basic and Clinical Physiology and Pharmacology},
  year = {2018},
  volume = {29},
  number = {1},
  pages = {19--27},
  doi = {10.1515/jbcpp-2016-0194}
}
Kostenlos starten →